NCT04574947CompletedPhase 4
Lidocaine And Neuromonitoring in Thyroid Surgery
Intravenous Or Topical Lidocaine And Neuromonitoring in Thyroid Surgery (IOLANT Study)
Source: ClinicalTrials.gov · Last updated 21 Mar 2024
Brief summary (registry, in English)
The aim of this study is to test the hypothesis that the quality of recovery with topical lidocaine is better than placebo.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 110 (actual)
- First submitted
- 24 Sept 2020
- Start date
- 25 Jan 2021
- Primary completion date
- 15 Oct 2023
- Lead sponsor
- Saint Petersburg State University, Russia
- Diseases
- Thyroid cancer
- NCT number
- NCT04574947
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 110
- From 25 Jan 2021 to the primary completion date, 15 Oct 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Emergency surgery
- Redo surgery
Other
- Contraindications for lidocaine use
- Pregnancy
- Enrolment to another randomised clinical trial within the last 30 days
Who the study is looking for
- Planned thyroid surgery
- Age\> 45 years
- Signed informed consent to participate in the study
Age in the registry: 45 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| St. Petersburg State University Hospital Coordinator of this site? Confirm its status | Saint Petersburg | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.